QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 

   

 

Health Affairs, 28, no. 2 (2009): 546-556
doi: 10.1377/hlthaff.28.2.546
© 2009 by Project HOPE
 
New Online
 * House Health Reform Bill
 * House Bill: Public Option
 * House Bill: Delivery Reform
 * Paying for Reform
 * Vetting AHIP's Report
 * Brief: Insurance Reform
This Article
* Figures Only
* Full Text (HTML)
* Reprint (PDF)
* Survey Instrument & Supp. Exhibit 4
* Submit a response to this article
* Alert me when this article is cited
* Alert me when Comments are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Shrank, W. H.
* Articles by Choudhry, N. K.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Shrank, W. H.
* Articles by Choudhry, N. K.
Related Collections
* Business Of Health
* Personal Experience ("Narrative Matters")
* Pharmaceuticals
* Public Opinion
* Quality Of Care
* Consumer Issues

DataWatch

Patients’ Perceptions Of Generic Medications

William H. Shrank, Emily R. Cox, Michael A. Fischer, Jyotsna Mehta and Niteesh K. Choudhry

Insurers and policymakers encourage the use of generic drugs to reduce costs, but generics remain underused. We conducted a national survey of commercially insured adults to evaluate their perceptions about generic drugs. Patients agreed that generics are less expensive and a better value than brand-name drugs, and are just as safe. However, although 56 percent reported that Americans should use more generics, only 37.6 percent prefer to take generics. We discuss perceptions about communicating with practitioners about generics, generic substitution, and policymakers’ role in influencing generic use. These findings underscore the challenge that providers, insurers, and policymakers face in stimulating the cost-effective use of medications.


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?


This article has been cited by other articles:


Home page
Health Aff (Millwood)Home page
K. Outterson and A. S. Kesselheim
How Medicare Could Get Better Prices On Prescription Drugs
Health Aff., September 1, 2009; 28(5): w832 - w841.
[Abstract] [Full Text] [PDF]



Home | Current Issue | Archives | Topic Collections | Search | Blog | Subscribe | Contact Us | Help

© 2001-2009 Project HOPE–The People-to-People Organization
Terms and Policies